Endoglin in the Spotlight to Treat Cancer
A spotlight has been shone on endoglin in recent years due to that fact of its potential to serve as both a reliable disease biomarker and a therapeutic target. Indeed, endoglin has now been assigned many roles in both physiological and pathological processes. From a molecular point of view, endogli...
Main Authors: | Teresa González Muñoz, Ana Teresa Amaral, Pilar Puerto-Camacho, Héctor Peinado, Enrique de Álava |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/6/3186 |
Similar Items
-
Endoglin (CD105) and VEGF as potential angiogenic and dissemination markers for colorectal cancer
by: Ana Nogués, et al.
Published: (2020-05-01) -
Hot and Cold Tumors: Is Endoglin (CD105) a Potential Target for Vessel Normalization?
by: Claudia Ollauri-Ibáñez, et al.
Published: (2021-03-01) -
Endoglin Targeting: Lessons Learned and Questions That Remain
by: Yingmiao Liu, et al.
Published: (2021-12-01) -
Anti-Human Endoglin (hCD105) Immunotoxin—Containing Recombinant Single Chain Ribosome-Inactivating Protein Musarmin 1
by: Begoña Barriuso, et al.
Published: (2016-06-01) -
The Role of Endoglin in Hepatocellular Carcinoma
by: Kuo-Shyang Jeng, et al.
Published: (2021-03-01)